KUKJEON PHARMACEUTICAL Co., Ltd (KOSDAQ:307750)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceutical Manufacturing and Sales	136.47B	122.00B	103.71B	85.35B
Pharmaceutical Manufacturing and Sales Growth	11.86%	17.63%	21.51%	-
Total	136.47B	122.00B	103.71B	85.35B
Total Growth	11.86%	17.63%	21.51%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
South Korea	136.47B	122.00B	103.71B	85.35B
South Korea Growth	11.86%	17.63%	21.51%	-
Total	136.47B	122.00B	103.71B	85.35B
Total Growth	11.86%	17.63%	21.51%	-

Source: S&P Global Market Intelligence.